FNAC still gold for thyroid
A popular MCQ post by Chaudhary Shafiullah reinforced that fine‑needle aspiration cytology remains the gold standard for thyroid nodule evaluation and provoked a practical discussion on best practices. The social thread’s engagement highlighted ongoing demand for FNA technique, ROSE, and cytotechnologist training in thyroid diagnostics. (x.com)
Respondents in the X thread pressed for wider use of ROSE; a 17‑study meta‑analysis of 24,649 thyroid nodules found pooled adequacy rose from 76% without ROSE to 92% with ROSE and a risk ratio of 1.22 (95% CI 1.12–1.32). (sciencedirect.com) (sciencedirect.com) A large single‑center series of 5,241 image‑guided FNABs reported cytotechnologists’ on‑site adequacy calls were correct in 95% of cases (2,637 of 2,784 adequacy assessments), supporting tasking cytotechnologists for ROSE in high‑volume programs. (acsjournals.onlinelibrary.wiley.com) (acsjournals.onlinelibrary.wiley.com) Workforce data cited in the thread match national vacancy trends: the ASCP 2022 Vacancy Survey showed the Cytology department had the highest projected five‑year retirement percentage at 19.6%, increasing pressure to train replacements for ROSE and FNA services. (criticalvalues.org / ASCP) (criticalvalues.org) Hands‑on training moves the needle: a 2‑day intensive ultrasound‑guided FNA workshop in Tanzania (26 participants) produced statistically significant pre‑to‑post improvements in ultrasound setup, lesion measurement, targeting technique, and smear preparation. (jgo.ascopubs.org / escholarship.org) (ascopubs.org) Institutional adequacy standards discussed in the thread mirror published criteria: the recommended adequacy threshold for thyroid FNA is ≥6 groups of well‑visualized follicular cells with ≥10 cells per group (with exceptions for obvious atypia or abundant colloid). (pathologyoutlines.com) (pathologyoutlines.com) Telecytology and tele‑ROSE surfaced repeatedly as solutions in replies; recent studies and reviews describe telecytology enabling remote on‑site adequacy assessment and primary diagnosis to expand ROSE coverage in smaller centers. (springer.com / link.springer.com) (link.springer.com) Practice protocols from the American Society of Cytopathology and a standardized J‑Am‑Soc‑Cytopathol report (Fetzer et al., 2020) document cytotechnologist‑led ROSE workflows that include immediate triage for ancillary studies and specimen allocation for molecular testing. (sciencedirect.com / jascjournal.org) (sciencedirect.com)
